These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11559952)
1. Report on the workshop: Von Willebrand factor and Thrombotic Thrombocytopenic Purpura. Moake JL; Sadler JE; Mannucci P; Ganguly P Am J Hematol; 2001 Oct; 68(2):122-6. PubMed ID: 11559952 [No Abstract] [Full Text] [Related]
2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245 [TBL] [Abstract][Full Text] [Related]
3. Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No. Remuzzi G J Thromb Haemost; 2003 Apr; 1(4):632-4. PubMed ID: 12871391 [No Abstract] [Full Text] [Related]
4. [TTP/HUS and VWF/ADAMTS-13]. Fujimura Y Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930 [No Abstract] [Full Text] [Related]
5. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance]. Korczowski B Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283 [TBL] [Abstract][Full Text] [Related]
6. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy. Robson WL; Tsai HM Pediatrics; 2002 Feb; 109(2):322-5. PubMed ID: 11826215 [No Abstract] [Full Text] [Related]
8. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Furlan M Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284 [TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Warwicker P; Goodship JA; Goodship TH N Engl J Med; 1999 Apr; 340(17):1368-9. PubMed ID: 10223877 [No Abstract] [Full Text] [Related]
10. Processing of von Willebrand factor by ADAMTS-13. Chung DW; Fujikawa K Biochemistry; 2002 Sep; 41(37):11065-70. PubMed ID: 12220170 [No Abstract] [Full Text] [Related]
11. [Plasma exchange therapy in patients with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome]. Ikeda Y; Kikuchi M Nihon Rinsho; 1992 Jan; 50 Suppl():293-7. PubMed ID: 1578694 [No Abstract] [Full Text] [Related]
12. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Sarkodee-Adoo C; Gojo I; Heyman MR N Engl J Med; 1999 Apr; 340(17):1368; author reply 1369. PubMed ID: 10223876 [No Abstract] [Full Text] [Related]
14. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction. Lämmle B; George JN Semin Hematol; 2004 Jan; 41(1):1-3. PubMed ID: 14727253 [No Abstract] [Full Text] [Related]
15. von Willebrand factor in thrombotic thrombocytopenic purpura. Furlan M; Lämmle B Thromb Haemost; 1999 Aug; 82(2):592-600. PubMed ID: 10605756 [No Abstract] [Full Text] [Related]
16. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. Tsai HM; Lian EC N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246 [TBL] [Abstract][Full Text] [Related]